Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of Talkspace (NasdaqCM:TALK) with a Buy recommendation. Analyst Price Forecast Suggests 82.80% Upside As of April 2, 2025, ...

Deal with Cantor Fitzgerald comes almost two years after Canaccord warned of a potentially ‘significant penalty’ related to ...

Analysts at Canaccord Genuity placed their target price and rating on oilfield services business Wood Group under review on ...

LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

Canaccord Genuity analyst Katie Lachapelle maintained a Buy rating on Sigma Lithium (SGML – Research Report) today and set a price target of ...

Sale of U.S. market making business reinforces alignment of Canaccord Genuity's U.S. business with its global capital markets platform TORONTO, April 1, 2025 /CNW/ - Canaccord Genuity Group Inc ...

Marker Therapeutics is advancing a unique multi antigen recognizing (MAR)-T cell therapy platform designed to target multiple tumor-associated antigens simultaneously, an approach that has shown ...

Detailed price information for Canaccord Genuity Group Inc (CF-T) from The Globe and Mail including charting and trades.

To join the virtual panel discussion, please contact your Canaccord Genuity conference representative. About Marker Therapeutics, Inc. Marker Therapeutics, Inc. is a Houston, TX-based clinical ...